GSK Annual Report 2002
GSK Annual Report 2002
GSK Annual Report 2002
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Financial record GlaxoSmithKline 147<br />
Pharmaceutical sales – International Q4 <strong>2002</strong> Q3 <strong>2002</strong> Q2 <strong>2002</strong> Q1 <strong>2002</strong><br />
£m CER % £m CER % £m CER % £m CER %<br />
CNS 120 20 107 18 113 24 96 15<br />
Depression 84 25 70 23 72 29 61 29<br />
Seroxat/Paxil 79 25 65 23 66 31 57 30<br />
Wellbutrin 5 21 5 23 6 11 4 21<br />
Migraine 16 (2) 14 (7) 16 43 11 33<br />
Imigran/Imitrex 13 (5) 12 (10) 15 49 9 35<br />
Naramig/Amerge 3 17 2 16 1 14 2 21<br />
Lamictal 10 5 9 19 11 22 10 32<br />
Requip 1 14 1 26 1 30 1 27<br />
Zyban 4 74 5 85 9 (35) 7 (48)<br />
Respiratory 173 4 138 11 157 12 155 13<br />
Seretide/Advair,<br />
Flixotide/Flovent, Serevent 102 20 83 28 94 28 83 35<br />
Seretide/Advair 41 67 36 86 39 93 31 >100<br />
Flixotide/Flovent 50 (2) 40 4 44 4 43 9<br />
Serevent 11 17 7 (3) 11 8 9 (8)<br />
Flixonase/Flonase 18 (3) 11 9 15 7 25 (7)<br />
Ventolin 33 (6) 30 1 32 (7) 29 (4)<br />
Becotide 6 (42) 5 (39) 7 (17) 7 (19)<br />
Anti-virals 119 4 109 6 118 4 104 9<br />
HIV 39 19 35 11 37 17 35 17<br />
Combivir 15 1 16 1 18 21 15 22<br />
Trizivir 5 >100 3 >100 2 >100 2 >100<br />
Epivir 9 2 9 (16) 9 (15) 10 (15)<br />
Retrovir 3 16 2 (5) 3 5 2 (9)<br />
Ziagen 6 86 4 42 5 31 4 47<br />
Agenerase 1 (55) 1 4 – – 2 70<br />
Herpes 54 (9) 50 – 55 (6) 45 (11)<br />
Valtrex 23 28 20 12 17 17 17 23<br />
Zovirax 31 (26) 30 (6) 38 (15) 28 (22)<br />
Zeffix 26 28 24 11 22 5 23 29<br />
Anti-bacterials 148 (11) 133 5 134 (1) 124 (6)<br />
Augmentin 44 (15) 44 7 44 3 40 (4)<br />
Zinnat/Ceftin 23 (16) 23 (8) 23 (2) 23 (3)<br />
Fortum 18 (11) 16 4 18 1 16 (13)<br />
Amoxil 22 1 12 (1) 12 (23) 13 (6)<br />
Metabolic and gastro-intestinal 113 (2) 88 (7) 108 (3) 95 (3)<br />
Avandia 26 65 16 30 18 64 19 >100<br />
Zantac 46 (22) 39 (23) 51 (17) 44 (12)<br />
Vaccines 86 6 87 30 80 10 69 17<br />
Hepatitis 16 12 15 1 19 14 18 (15)<br />
Infanrix 11 (29) 19 69 16 26 12 24<br />
Oncology and emesis 21 (4) 20 9 24 9 20 20<br />
Zofran 17 (2) 16 10 18 7 15 22<br />
Hycamtin 1 (42) 2 (4) 2 41 2 12<br />
Cardiovascular 21 18 19 17 20 11 18 20<br />
Coreg 3 30 3 18 2 24 3 39<br />
Arthritis (Relafen) 2 (22) 2 (15) 2 (15) 3 (30)<br />
Other 132 (12) 133 (9) 132 (7) 154 9<br />
Total pharmaceutical sales 935 – 836 6 888 5 838 7
Change language